This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Taegtmeyer, H. Search for Related Content PubMed PubMed Citation Articles by Taegtmeyer, H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB GLUCOSE Medline Plus Health Information Heart Failure Related Collections Heart failure - basic studies Hypertrophy Metabolism Glucose intolerance Related Article

(Circulation. 2002;106:2043.)
© 2002 American Heart Association, Inc.

Editorial

Switching Metabolic Genes to Build a Better Heart

Heinrich Taegtmeyer, MD, DPhil

From the University of Texas Houston Medical School, Department of Internal Medicine, Division of Cardiology, Houston, Tex.

Correspondence to Heinrich Taegtmeyer, MD, DPhil, University of Texas Houston Medical School, Division of Cardiology, 6431 Fannin, MSB 1.246, Houston TX 77030. E-mail Heinrich.Taegtmeyer@uth.tmc.edu

Key Words: Editorials • metabolism • hypertrophy • heart failure • glucose

An extract of the first 250 words of the full text is provided, because this article has no abstract.

The heart makes its living by liberating energy from a variety of oxidizable substrates, either simultaneously or vicariously.¹ Because of built-in mechanisms that choose the most efficient substrate for a given physiological environment, the heart is a true metabolic omnivore.² The link between metabolism and function of the heart was discovered by Langendorff³ when he demonstrated that the mammalian heart receives oxygen and nutrients through the coronary circulation and not through the endocardium, as it had been assumed until then. Early investigators also knew already that the heart oxidizes fatty acids and glucose,⁴ and myocardial fuel economy became a focus of biochemical investigation in the 1960s. Biochemists "discovered" the heart as a convenient bag of enzymes to study muscle metabolism and found that fatty acids suppress glucose oxidation, chiefly at the level of the pyruvate dehydrogenase complex.⁵ Conversely, we later found that glucose suppresses fatty acid oxidation,¹ chiefly at the level of fatty acid entry into the mitochondria. In short, fuel metabolism in the heart is highly regulated, allowing the heart to respond to substrate availability, circulating hormones (such as insulin or catecholamines), coronary flow, and workload by choosing the "right" substrate at the right moment. Unless blood supply is curtailed, as it is the case in ischemia, the heart is never short of fuel to burn.

See p 2125

Control and Regulation

What is, then, the principle that underlies substrate switching? As every nutritionist knows, fat has a higher caloric value than carbohydrates; at the same time, the oxidation of carbohydrates results . . . [Full Text of this Article]

Related Article:

Cardiac-Specific Overexpression of GLUT1 Prevents the Development of Heart Failure Attributable to Pressure Overload in Mice

Ronglih Liao, Mohit Jain, Lei Cui, Jessica D’Agostino, Francesco Aiello, Ivan Luptak, Soeun Ngoy, Richard M. Mortensen, and Rong Tian
Circulation 2002 106: 2125-2131. [Abstract] [Full Text]

This article has been cited by other articles:

				L. Hue and H. Taegtmeyer The Randle cycle revisited: a new head for an old hat Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E578 - E591. [Abstract] [Full Text] [PDF]

				T. Doenst, H. Bugger, M. Schwarzer, G. Faerber, M. A. Borger, and F. W. Mohr Three good reasons for heart surgeons to understand cardiac metabolism Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 862 - 871. [Abstract] [Full Text] [PDF]

				R. M. Witteles and M. B. Fowler Insulin-Resistant Cardiomyopathy: Clinical Evidence, Mechanisms, and Treatment Options J. Am. Coll. Cardiol., January 15, 2008; 51(2): 93 - 102. [Abstract] [Full Text] [PDF]

				L. C. Heather, M. A. Cole, C. A. Lygate, R. D. Evans, D. J. Stuckey, A. J. Murray, S. Neubauer, and K. Clarke Fatty acid transporter levels and palmitate oxidation rate correlate with ejection fraction in the infarcted rat heart Cardiovasc Res, December 1, 2006; 72(3): 430 - 437. [Abstract] [Full Text] [PDF]

				A. Mullick, Z. Leon, G. Min-Oo, J. Berghout, R. Lo, E. Daniels, and P. Gros Cardiac Failure in C5-Deficient A/J Mice after Candida albicans Infection. Infect. Immun., August 1, 2006; 74(8): 4439 - 4451. [Abstract] [Full Text] [PDF]

				O. Dewald, S. Sharma, J. Adrogue, R. Salazar, G. D. Duerr, J. D. Crapo, M. L. Entman, and H. Taegtmeyer Downregulation of Peroxisome Proliferator-Activated Receptor-{alpha} Gene Expression in a Mouse Model of Ischemic Cardiomyopathy Is Dependent on Reactive Oxygen Species and Prevents Lipotoxicity Circulation, July 19, 2005; 112(3): 407 - 415. [Abstract] [Full Text] [PDF]

				M. Benderdour, G. Charron, B. Comte, R. Ayoub, D. Beaudry, S. Foisy, D. deBlois, and C. Des Rosiers Decreased cardiac mitochondrial NADP+-isocitrate dehydrogenase activity and expression: a marker of oxidative stress in hypertrophy development Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2122 - H2131. [Abstract] [Full Text] [PDF]

				H. Taegtmeyer Cardiac Metabolism as a Target for the Treatment of Heart Failure Circulation, August 24, 2004; 110(8): 894 - 896. [Full Text] [PDF]

				M. V. Simoes, S. Egert, S. Ziegler, M. Miyagawa, S. Reder, T. Lehner, N. Nguyen, M. J. Charron, and M. Schwaiger Delayed response of insulin-stimulated fluorine-18 deoxyglucose uptake in glucose transporter-4-null mice hearts J. Am. Coll. Cardiol., May 5, 2004; 43(9): 1690 - 1697. [Abstract] [Full Text] [PDF]

				S. Sharma, H. Taegtmeyer, J. Adrogue, P. Razeghi, S. Sen, K. Ngumbela, and M. F. Essop Dynamic changes of gene expression in hypoxia-induced right ventricular hypertrophy Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1185 - H1192. [Abstract] [Full Text] [PDF]

				R. Ventura-Clapier, A. Garnier, and V. Veksler Energy metabolism in heart failure J. Physiol., February 15, 2004; 555(1): 1 - 13. [Abstract] [Full Text] [PDF]

				K. Feingold, M. S. Kim, J. Shigenaga, A. Moser, and C. Grunfeld Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E201 - E207. [Abstract] [Full Text] [PDF]

				Y. Hayakawa, M. Chandra, W. Miao, J. Shirani, J. H. Brown, G. W. Dorn II, R. C. Armstrong, and R. N. Kitsis Inhibition of Cardiac Myocyte Apoptosis Improves Cardiac Function and Abolishes Mortality in the Peripartum Cardiomyopathy of G{alpha}q Transgenic Mice Circulation, December 16, 2003; 108(24): 3036 - 3041. [Abstract] [Full Text] [PDF]

				C. S. Apstein The benefits of glucose-insulin-potassium for acute myocardial infarction (and some concerns) J. Am. Coll. Cardiol., September 3, 2003; 42(5): 792 - 795. [Full Text] [PDF]

				H. Taegtmeyer Improving Energy Metabolism in the Postischemic Heart-The Story of GIK Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2003; 7(1): 67 - 76. [Abstract] [PDF]

				C. J. Tack Insulin Resistance and Acute Cardiovascular Complications Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2003; 7(1): 85 - 90. [PDF]